E7 recruits HDAC1/2 and EZH2, the methyltransferase component of PRC2, promoting repressive H3K27me3 marks on tumor suppressors​ (Soto et al., 2017; Liu et al., 2023; Durzynska et al., 2017). This evidence concerns the gene EZH2 and neoplasm.